Cargando…

Assessing heterogeneity of treatment effect in multiple sclerosis trials

Multiple sclerosis (MS) is heterogeneous with respect to outcomes, and evaluating possible heterogeneity of treatment effect (HTE) is of high interest. HTE is non-random variation in the magnitude of a treatment effect on a clinical outcome across levels of a covariate (i.e. a patient attribute or s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sormani, Maria Pia, Chataway, Jeremy, Kent, David M, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Meeting Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413777/ https://www.ncbi.nlm.nih.gov/pubmed/37555493 http://dx.doi.org/10.1177/13524585231189673

Ejemplares similares

Enhancing diversity of clinical trial populations in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Enhancing involvement of people with multiple sclerosis in clinical trial design
por: Gray, Emma, et al.
Publicado: (2023)

Improving the efficiency of clinical trials in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study
por: Palladino, Raffaele, et al.
Publicado: (2021)

Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study
por: Palladino, Raffaele, et al.
Publicado: (2023)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

An Italian programme for COVID-19 infection in multiple sclerosis
por: Sormani, Maria Pia
Publicado: (2020)

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
por: Nickerson, Molly, et al.
Publicado: (2013)

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

Effect of comorbidity on mortality in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Quantitative Assessment of Finger Motor Impairment in Multiple Sclerosis
por: Bonzano, Laura, et al.
Publicado: (2013)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Multiple sclerosis in First Nations Canadians: A pilot comparison study
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years
por: Hawton, Annie, et al.
Publicado: (2020)

The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis
por: Branger, Pierre, et al.
Publicado: (2016)

Decentralised clinical trials in multiple sclerosis research
por: Garjani, Afagh, et al.
Publicado: (2022)

The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids
por: Rakusa, Martin, et al.
Publicado: (2023)

Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Women's Health in Multiple Sclerosis: A Scoping Review
por: Ross, Lindsay, et al.
Publicado: (2022)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial
por: Williams, Thomas E., et al.
Publicado: (2022)

Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Development of an indicator of smoking status for people with multiple sclerosis in administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Clinical course of multiple sclerosis and patient experiences during breast cancer treatment
por: Nylander, Alyssa N, et al.
Publicado: (2023)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning
por: Falet, Jean-Pierre R., et al.
Publicado: (2022)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2020)

Health service utilization in immigrants with multiple sclerosis
por: Rotstein, Dalia L., et al.
Publicado: (2020)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis
por: Rotstein, Dalia, et al.
Publicado: (2021)

COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
por: Albanese, Angela, et al.
Publicado: (2022)

Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review
por: Alexander, Sarah, et al.
Publicado: (2020)

Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis
por: Pia Sormani, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ktpdo4a2mlregdckktkkjp3ls6